Biotech

All Articles

Actinogen's cortisol blocker stops working phase 2 anxiety study

.Actinogen Medical's cortisol blocker has skipped the key endpoint of a stage 2 study in anxiety, le...

Bivictrix decides going private only technique to take ADC into clinic

.Antibody-drug conjugates (ADCs) have actually gone to the center of numerous a billion-dollar biobu...

TPG leadings up funds to $580M for assets across lifestyle sciences

.Property manager TPG, which has supported biotechs including Sionna Rehabs as well as Santa Clam An...

Merck ceases phase 3 TIGIT test in lung cancer cells for impossibility

.Merck &amp Co.'s TIGIT system has actually suffered another drawback. Months after shuttering a per...

After a tough year, Exscientia folds into Recursion

.After a year determined by pipeline cuts, the departure of its own chief executive officer and also...

Cullinan, after $25M package, hands back bispecific to Harbour

.Cullinan Therapy was actually blown away good enough along with Port BioMed's bispecific invulnerab...

A more detailed check out Strong Biotech's Brutal 15

.In this particular full week's episode of "The Top Pipe," our team are actually diving in to Feroci...

Lilly deals with period 2 failing of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's party celebrating the approval of Alzheimer's...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable management hirings, firings...

Lykos will certainly inquire FDA to rethink its choice complying with rejection of MDMA therapy for post-traumatic stress disorder

.Observing a bad presenting for Lykos Therapies' MDMA applicant for post-traumatic stress disorder a...